Microbiome Therapeutics Targeting Nervous System

Holobiome is focused on harnessing the potential of the human microbiome to develop innovative therapies aimed at enhancing overall health. The company is dedicated to translating cutting-edge research into practical applications, particularly in the realm of probiotics and targeted health solutions. By leveraging insights from the gut microbiome, Holobiome aims to address significant challenges in modern medicine, emphasizing the importance of scientific rigor in their approach to product development.

Founded by research scientists from Northeastern University, Holobiome's mission is to unlock the therapeutic potential of gut microbes. The company is committed to improving global health through the discovery and development of first-in-class therapies that are informed by the latest scientific findings. Their work underscores the belief that the microbiome may play a crucial role in addressing various health issues, positioning Holobiome at the forefront of microbiome research and its applications in healthcare.

United States

Holobiome is building a platform to solve the complexities of the human gut microbiome, which is then used to deliver its potential to multiple marketplaces to improve human health. Our initial focus is on mapping and manipulating the gut-brain-axis via next generation probiotics.

Holobiome

Company Details